- Home
- / Bioiberica
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Bioiberica financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Revenue
$346.7 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|
| Revenue | 234.0M | 257.2M | 346.7M |
| Revenue growth, % | 9.9% | 34.8% | |
| Cost of goods sold | 140.0M | 149.2M | 190.3M |
| Gross profit | 94.0M | 108.0M | 156.4M |
| Gross profit margin, % | 40.2% | 42.0% | 45.1% |
| General and administrative expense | 82.8M | 83.0M | 95.2M |
| Operating expense total | 89.2M | 91.5M | 105.8M |
| Depreciation and amortization | 5.3M | 6.7M | 6.6M |
| EBIT | 4.8M | 16.7M | 50.6M |
| EBIT margin, % | 2.1% | 6.5% | 14.6% |
| Interest income | 7.4M | 5.8M | 2.7M |
| Interest expense | 6.5M | 2.3M | 900.0K |
| Pre tax profit | 5.7M | 20.1M | 52.4M |
| Income tax expense | (200.0K) | 2.3M | 12.0M |
| Net Income | 5.9M | 17.8M | 40.5M |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |